Where Ionis Pharmaceuticals Stands With Analysts
Where Ionis Pharmaceuticals Stands With Analysts
ionis pharmaceuticals目前与分析师的立场
A clear picture...Ionis Pharmaceuticals (NASDAQ:IONS) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Ionis Pharmaceuticals（纳斯达克：IONS）在上个季度接受了4位分析师的分析，从看好到谨慎看淡，观点各异。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high estimate of $70.00, and a low estimate of $55.00. Consistency is reflected as the current average remains at the same level as the previous average price target.
分析师评估的12个月价格目标揭示了更多见解，其中包括平均目标为$62.5，最高估价为$70.00，最低估价为$55.00。当前平均值与先前的平均价格目标保持一致。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
A clear picture...
通过对...
登录免费看全文
登录/注册
热门讨论
FOMC维持利率但不确定性高企：美股后市走向如何？
🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？
Moo Live
03/20 02:25
联邦公开市场委员会新闻发布会，2025年3月19日